Fuyama S, Yamamoto H, Fujii Y, Arai S
Cancer Res. 1986 Nov;46(11):5548-52.
Our previous study showed that spleen cells from BALB/c mice bearing RL male 1 lymphoma inhibited the growth of RL male 1 lymphoma by the Winn-type adoptive transfer assay. Although this antitumor activity was mediated by the T-cell subset manifesting the surface phenotype of cytotoxic T-lymphocytes (CTLs), this antitumor activity of spleen cells was not detected by the in vitro cell-mediated cytotoxicity assay (4-h 51Cr release assay). The present study is concerned with the hypothesis that the maturation of the CTLs directed against RL male 1 may be arrested in spleens of the RL male 1-bearing mice and the differentiation into mature CTLs may occur at the tumor site; i.e., the immature CTLs (activated precytotoxic T-cells) may acquire the killing activity when they contact tumor cells at the tumor site. This report shows that BALB/c mice bearing the progressive RL male 1 lymphoma were able to generate CTLs against RL male 1 in the peritoneal cavities when the mice were inoculated i.p. with the irradiated RL male 1 cells. The cytotoxic activity of the peritoneal exudate cells of the RL male 1-bearing mice appeared 3 to 5 days after i.p. inoculation of the irradiated RL male 1 cells and rapidly decreased on day 7 after inoculation. In addition, spleen cells from the RL male 1-bearing mice after i.p. inoculation of the irradiated RL male 1 cells were not cytotoxic, suggesting a highly localized response. The cytotoxic effector cells induced in the peritoneal cavities consisted of T-lymphocytes and natural killer cells. Both cell types were simultaneously induced in the peritoneal cavities of the RL male 1-bearing mice. The T-cell subset mediating cytolytic activity against RL male 1 was shown to consist of Lyt-1+2+ T-cells which were defined by cytolysis with anti-Lyt-1 or anti-Lyt-2 antibody and complement. On the other hand, the normal BALB/c mice inoculated i.p. with the irradiated RL male 1 cells generated natural killer cells in the peritoneal cavities and spleens but the CTLs were not induced. The results from the present and previous studies suggest that precytotoxic or immature cytotoxic T-cells in spleens of the tumor-bearing mice migrate into the circulation and then mature CTLs develop at the tumor site.
我们之前的研究表明,携带RL雄性1淋巴瘤的BALB/c小鼠的脾细胞通过Winn型过继转移试验抑制了RL雄性1淋巴瘤的生长。尽管这种抗肿瘤活性是由表现出细胞毒性T淋巴细胞(CTL)表面表型的T细胞亚群介导的,但脾细胞的这种抗肿瘤活性在体外细胞介导的细胞毒性试验(4小时51Cr释放试验)中未被检测到。本研究关注的假说是,针对RL雄性1的CTL成熟可能在携带RL雄性1的小鼠脾脏中停滞,而向成熟CTL的分化可能发生在肿瘤部位;即,未成熟的CTL(活化的前细胞毒性T细胞)在肿瘤部位与肿瘤细胞接触时可能获得杀伤活性。本报告表明,当给携带进行性RL雄性1淋巴瘤的BALB/c小鼠腹腔注射经辐照的RL雄性1细胞时,这些小鼠能够在腹腔中产生针对RL雄性1的CTL。携带RL雄性1的小鼠腹腔渗出细胞的细胞毒性活性在腹腔注射经辐照的RL雄性1细胞后3至5天出现,并在接种后第7天迅速下降。此外,腹腔注射经辐照的RL雄性1细胞后,携带RL雄性1的小鼠的脾细胞没有细胞毒性,这表明存在高度局部化的反应。在腹腔中诱导的细胞毒性效应细胞由T淋巴细胞和自然杀伤细胞组成。这两种细胞类型在携带RL雄性1的小鼠腹腔中同时被诱导。介导针对RL雄性1的溶细胞活性的T细胞亚群被证明由Lyt-1+2+ T细胞组成,这些细胞通过用抗Lyt-1或抗Lyt-2抗体及补体进行细胞溶解来定义。另一方面,腹腔注射经辐照的RL雄性1细胞的正常BALB/c小鼠在腹腔和脾脏中产生了自然杀伤细胞,但未诱导出CTL。本研究和之前研究的结果表明,荷瘤小鼠脾脏中的前细胞毒性或未成熟细胞毒性T细胞迁移到循环中,然后在肿瘤部位发育成熟为CTL。